What is the equity of Wuhan Hvsen Biotechnology Co this year?
Wuhan Hvsen Biotechnology Co has equity of 1.51 B CNY this year.
Wuhan Hvsen Biotechnology Co Equity 2024
Wuhan Hvsen Biotechnology Co Equity
1.51 B CNY
Ticker
300871.SZ
ISIN
CNE1000047H6
In 2024, Wuhan Hvsen Biotechnology Co's equity was 1.51 B CNY, a -2.09% increase from the 1.54 B CNY equity in the previous year.
Wuhan Hvsen Biotechnology Co Aktienanalyse
What does Wuhan Hvsen Biotechnology Co do?
Wuhan Hvsen Biotechnology Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Wuhan Hvsen Biotechnology Co's Equity
Wuhan Hvsen Biotechnology Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Wuhan Hvsen Biotechnology Co's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Wuhan Hvsen Biotechnology Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Wuhan Hvsen Biotechnology Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Wuhan Hvsen Biotechnology Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Wuhan Hvsen Biotechnology Co Stock
What was the equity of Wuhan Hvsen Biotechnology Co compared to the previous year?
The equity of Wuhan Hvsen Biotechnology Co has increased/decreased by -2.09% decreased compared to the previous year.
What impact does a high equity have on investors of Wuhan Hvsen Biotechnology Co?
A high equity is advantageous for investors of Wuhan Hvsen Biotechnology Co as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Wuhan Hvsen Biotechnology Co?
A low equity can be a risk for investors of Wuhan Hvsen Biotechnology Co, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Wuhan Hvsen Biotechnology Co affect the company?
An increase in equity of Wuhan Hvsen Biotechnology Co can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Wuhan Hvsen Biotechnology Co affect the company?
A reduction in equity of Wuhan Hvsen Biotechnology Co can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Wuhan Hvsen Biotechnology Co?
Some factors that can affect the equity of Wuhan Hvsen Biotechnology Co include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Wuhan Hvsen Biotechnology Co so important for investors?
The equity of Wuhan Hvsen Biotechnology Co is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Wuhan Hvsen Biotechnology Co take to change the equity?
To change equity, Wuhan Hvsen Biotechnology Co can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Wuhan Hvsen Biotechnology Co pay?
Over the past 12 months, Wuhan Hvsen Biotechnology Co paid a dividend of 0.3 CNY . This corresponds to a dividend yield of about 3.14 %. For the coming 12 months, Wuhan Hvsen Biotechnology Co is expected to pay a dividend of 0.3 CNY.
What is the dividend yield of Wuhan Hvsen Biotechnology Co?
The current dividend yield of Wuhan Hvsen Biotechnology Co is 3.14 %.
When does Wuhan Hvsen Biotechnology Co pay dividends?
Wuhan Hvsen Biotechnology Co pays a quarterly dividend. This is distributed in the months of June, May, July, June.
How secure is the dividend of Wuhan Hvsen Biotechnology Co?
Wuhan Hvsen Biotechnology Co paid dividends every year for the past 6 years.
What is the dividend of Wuhan Hvsen Biotechnology Co?
For the upcoming 12 months, dividends amounting to 0.3 CNY are expected. This corresponds to a dividend yield of 3.17 %.
In which sector is Wuhan Hvsen Biotechnology Co located?
Wuhan Hvsen Biotechnology Co is assigned to the 'Health' sector.
Wann musste ich die Aktien von Wuhan Hvsen Biotechnology Co kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Wuhan Hvsen Biotechnology Co from 5/29/2024 amounting to 0.27 CNY, you needed to have the stock in your portfolio before the ex-date on 5/29/2024.
When did Wuhan Hvsen Biotechnology Co pay the last dividend?
The last dividend was paid out on 5/29/2024.
What was the dividend of Wuhan Hvsen Biotechnology Co in the year 2023?
In the year 2023, Wuhan Hvsen Biotechnology Co distributed 0.331 CNY as dividends.
In which currency does Wuhan Hvsen Biotechnology Co pay out the dividend?
The dividends of Wuhan Hvsen Biotechnology Co are distributed in CNY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Wuhan Hvsen Biotechnology Co
Our stock analysis for Wuhan Hvsen Biotechnology Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Wuhan Hvsen Biotechnology Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Wuhan Hvsen Biotechnology Co Revenue
- Wuhan Hvsen Biotechnology Co Net Income
- Wuhan Hvsen Biotechnology Co P/E
- Wuhan Hvsen Biotechnology Co P/S
- Wuhan Hvsen Biotechnology Co EBIT
- Wuhan Hvsen Biotechnology Co Dividend
- Wuhan Hvsen Biotechnology Co Stocks
- Wuhan Hvsen Biotechnology Co Market capitalization
- Wuhan Hvsen Biotechnology Co Debt
- Wuhan Hvsen Biotechnology Co Liabilities
- Wuhan Hvsen Biotechnology Co Equity
- Wuhan Hvsen Biotechnology Co AAQS
- Wuhan Hvsen Biotechnology Co Employees
- Wuhan Hvsen Biotechnology Co ROE
- Wuhan Hvsen Biotechnology Co ROA
- Wuhan Hvsen Biotechnology Co ROCE